Recent Finacing
Recent Raise
Aprea Therapeutics is a clinical-stage biopharmaceutical company developing p53-reactivating small molecules, notably APR-246, in clinical trials for MDS, AML and ovarian cancer while advancing second-generation candidates.
Recent Investors
Total Raised
Funding rounds
Investors